Repligen (RGEN) Total Liabilities (2010 - 2026)

Repligen (RGEN) has 17 years of Total Liabilities data on file, last reported at $825.3 million in Q1 2026.

• Total Liabilities for Q1 2026 came in at $825.3 million, down 4.77% year-over-year; the trailing twelve-month figure through Mar 2026 was $825.3 million (down 4.77% YoY), and the FY2025 annual result was $843.6 million, down 1.56% from the prior year.
• Total Liabilities fell to $825.3 million in Q1 2026 per RGEN's latest filing, from $843.6 million in the prior quarter.
• Over five years, Total Liabilities peaked at $888.1 million in Q1 2024 and troughed at $549.0 million in Q3 2023.
• A 5-year average of $752.9 million and a median of $825.3 million in 2026 frame the typical range for Total Liabilities.
• The sharpest annual moves came in 2022 and 2023: Total Liabilities surged 66.37% in 2022, then decreased 12.5% in 2023.
• A 5-year view of Total Liabilities shows it stood at $620.9 million in 2022, then soared by 39.53% to $866.3 million in 2023, then decreased by 1.08% to $856.9 million in 2024, then fell by 1.56% to $843.6 million in 2025, then retreated by 2.16% to $825.3 million in 2026.
• Business Quant data shows RGEN's Total Liabilities at $825.3 million in Q1 2026, $843.6 million in Q4 2025, and $840.6 million in Q3 2025.